Expanded Access Remdesivir (RDV; GS-5734™)
NO_LONGER_AVAILABLE
Conditions studied: Coronavirus Disease 2019
In brief
Disease caused by 2019 Novel Coronavirus also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Key facts
- Study ID
- NCT04302766
- Run by
- U.S. Army Medical Research and Development Command
- Last updated by the study team
- 2022-02-17
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- DoD-affiliated personnel as defined in DoDI 6200.02, which includes emergency-essential civilian employees and/or contractor personnel accompanying the Armed Forces who are subject to the same health risk as military personnel
- Have a laboratory-confirmed COVID-19 diagnosis with moderate to severe disease presentation as determined by the principal investigator
- Patient or legally authorized representative (LAR) provides written informed consent, except as noted in 21 CFR 50.23
- Understands and agrees to comply with planned study procedures
- Available for clinical follow-up for duration of the treatment and follow-up period
- Woman of childbearing potential must
- Have a negative pregnancy test within 24 hours before starting treatment
- Agree not to become pregnant during treatment and for 1 months after receiving remdesivir (Treatment will be a maximum of 10 doses given over a 10-day interval)
- Use at least 2 reliable forms of effective contraception, including 1 barrier method, during treatment and for 1 month after the treatment period
You may not qualify if…
- ALT/AST ≥ 5 times the upper limit of normal
- Stage 4 severe kidney disease or requiring dialysis (i.e. eGFR <30)
- Anticipated transfer to another hospital that is not a study site within 72 hours
- Allergy to any components of the study medication [GS-5734, sulfobutylether β-cyclodextrin sodium (SBECD) and hydrochloric acid and/or sodium hydroxide]
- Concomitant antiviral therapy (lopinavir/ritonavir [Kaletra])
- Pregnant or nursing
Where it is running
- Naval Medical Center San Diego — San Diego, California, United States
- Naval Hospital Jacksonville — Jacksonville, Florida, United States
- Benning Martin Army Community Hospital — Fort Benning, Georgia, United States
- Eisenhower Army Medical Center — Fort Gordon, Georgia, United States
- Tripler Army Medical Center — Tripler AMC, Hawaii, United States
- Blanchfield Army Community Hospital — Fort Campbell North, Kentucky, United States
- Walter Reed National Military Medical Center — Bethesda, Maryland, United States
- Womack Army Medical Center — Fort Bragg, North Carolina, United States
- Naval Medical Center Camp Lejeune — Marine Corps Base Camp Lejeune, North Carolina, United States
- William Beaumont Army Medical Center — El Paso, Texas, United States
- Carl R. Darnall Army Medical Center — Fort Hood, Texas, United States
- Brooke Army Medical Center — Fort Sam Houston, Texas, United States
- Naval Medical Center Portsmouth — Portsmouth, Virginia, United States
- Madigan Army Medical Center — Tacoma, Washington, United States
- Craig Joint Theater Hospital — Bagrām, Afghanistan
- NATO Role 3 Multinational Medical Unit Kandahar Air Field — Kandahar, Afghanistan
- EMF Camp Lemonnier — Djibouti, Djibouti
- Landstuhl Regional Medical Center — Landstuhl, APO AE, Germany
- US Naval Hospital Guam — Hagåtña, Guam
- Baghdad Diplomatic Support Center — Baghdad, Iraq
- US Naval Hospital Okinawa — Okinawa, Japan
- US Military Hospital Kuwait 411th Hospital Center — Kuwait City, Kuwait
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.